These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24480800)

  • 1. Comparison of RECIST 1.0 and RECIST 1.1 on computed tomography in patients with metastatic colorectal cancer.
    Jang HJ; Kim BC; Kim HS; Kim JH; Song HH; Kim JB; Park JJ; Yoon SN; Woo JY; Zang DY
    Oncology; 2014; 86(2):117-21. PubMed ID: 24480800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.
    Chung WS; Park MS; Shin SJ; Baek SE; Kim YE; Choi JY; Kim MJ
    AJR Am J Roentgenol; 2012 Oct; 199(4):809-15. PubMed ID: 22997372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.
    Machida N; Yoshino T; Boku N; Hironaka S; Onozawa Y; Fukutomi A; Yamazaki K; Yasui H; Taku K; Asaka M
    Jpn J Clin Oncol; 2008 Oct; 38(10):689-94. PubMed ID: 18845522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases.
    van Kessel CS; Samim M; Koopman M; van den Bosch MA; Borel Rinkes IH; Punt CJ; van Hillegersberg R
    Eur J Cancer; 2013 Jul; 49(11):2486-93. PubMed ID: 23692811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST.
    Fang WJ; Lam KO; Ng SC; Choi CW; Kwong DL; Zheng SS; Lee VH
    Asian Pac J Cancer Prev; 2013; 14(7):4151-5. PubMed ID: 23991968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
    Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
    Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
    Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.
    Ozaki Y; Shindoh J; Gonoi W; Nishioka Y; Kondoh C; Tanabe Y; Matoba S; Kuroyanagi H; Hashimoto M; Takano T
    BMC Cancer; 2018 Feb; 18(1):138. PubMed ID: 29402244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    Choi YR; Kim JH; Park SJ; Hur BY; Han JK
    PLoS One; 2017; 12(8):e0182596. PubMed ID: 28797089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor response assessment by measuring the single largest lesion per organ in patients with advanced non-small cell lung cancer.
    Kim HS; Kim JH; Yang I
    Lung Cancer; 2014 Sep; 85(3):385-9. PubMed ID: 25074845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K; Nielsen D; Jensen BV; Hendel HW
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria.
    Trillet-Lenoir V; Freyer G; Kaemmerlen P; Fond A; Pellet O; Lombard-Bohas C; Gaudin JL; Lledo G; Mackiewicz R; Gouttebel MC; Moindrot H; Boyer JD; Chassignol L; Stremsdoerfer N; Desseigne F; Moreau JM; Hedelius F; Moraillon A; Chapuis F; Bleuse JP; Barbier Y; Heilmann MO; Valette PJ
    Br J Radiol; 2002 Nov; 75(899):903-8. PubMed ID: 12466256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer.
    Huellner MW; Hennedige TP; Winterhalder R; Zander T; Venkatesh SK; Yong WP; Soo RA; Seifert B; Treumann TC; Strobel K; Veit-Haibach P
    Cancer Imaging; 2012 May; 12(1):212-24. PubMed ID: 22750105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
    Liu K; Li G; Fan C; Zhou C; Li J
    Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure.
    Zacharia TT; Saini S; Halpern EF; Sumner JE
    AJR Am J Roentgenol; 2006 Apr; 186(4):1067-70. PubMed ID: 16554580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ideal number of target lesions per organ to measure in metastatic colorectal cancer.
    Kim HS; Kim JH
    Oncol Lett; 2014 Oct; 8(4):1896-1900. PubMed ID: 25202433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of hepatic arterial infusion therapy and FOLFOX for colorectal cancer with multiple unresectable liver metastases causing severe liver dysfunction].
    Suto T; Sato T; Mori N; Takano N; Ishiyama K; Sakurai N; Saito K; Iizawa H; Ikeda E
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):71-6. PubMed ID: 19151566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.